The Animal Stem Cell Therapy market is expected to grow at a CAGR of 5.2% to reach US$ 437.3 Mn in 2032.

Because of the merits of animal stem cell therapy, the new, healthy skin tissue can be created, collagen can be produced, hair can regrow after being cut or lost, and scar tissue can be replaced with new healthy tissue. Experimental surgical advances have made it possible to create consistent and predictable impairments following calibrated spinal injuries that are quite close to human disease. Another benefit is the opportunity to leverage cell delivery and animal monitoring equipment and procedures established for human use

Covid-19 Impact & Market Status

The COVID-19 pandemic has shaken the animal stem cell treatment industry in 2020, accompanied by a shift in focus away from animal stem cell therapy as vaccines for the pandemic are developed. As a result, the market value of animal stem cell treatment fell in 2020; nevertheless, the market is predicted to expand modestly throughout the forecast period.

The Dog Segment is likely to grow at a faster pace

The market is separated into cat, horse, dog, and other categories depending on the application. The dog sector of the worldwide animal stem cell therapy market is expected to develop at the fastest market is projected to witness, owing to factors such as a rising number of dog owners who choose treatment alternatives that do not harm animals. Furthermore, the bulk of competitors in the market are focusing their expenditures in animal stem cell treatment research and development on the dog sector.

The Veterinary Hospitals Segment is likely to grow at a faster pace

The Animal Stem Cell Therapy industry's end-user segment is classified into three categories: Research Organizations, Veterinary Clinics, and Veterinary Hospitals. Stem cell treatment is the most promising and versatile approach for restoring function and improving animal health in veterinary facilities. Canine stem cell therapy is the most common use, which is predicted to drive the veterinary hospital market forward.

North American region is accounted for the largest market share

North America is a market leader for animal stem cell therapy globally as medical understanding advances. Due to the high demand for therapy, it holds a considerable market share in North America. Animal stem cell therapy is in high demand in North America, thanks to the large base of pet owners and the increased government funding for the health of animals that are revitalizing the business.

In experiments, animal stem cell therapy has been found to assist boost the development of new healthy skin tissue, enhance collagen synthesis, promote hair growth after injuries or loss of hair, and replace damaged tissue with newly created healthy tissue.

Animal stem cells are being utilized to help pets recover from illnesses and injuries. Stem cells have the potential to proliferate and differentiate into cells with specific functions that can be used to repair bodily tissues that have been damaged by injury or illness. They are injected into the body to heal injured muscles, joints, and ligaments caused by arthritis or injury. Stem cells extracted from the pet's own bone marrow are used to treat certain malignancies. After an acute or chronic insult, stem cell treatments are utilized to overcome the body's incapacity to rebuild damaged tissues and metabolic functions.

The global animal stem cell therapy market anticipated to reach US$ 425.1 Million in 2032, growing at a CAGR of 4.9% during 2022-2032. Animal stem cell treatment is gaining popularity around the world due to the possibility of using an animal's stem cells to treat illness or difficulties. This technique is well-known for helping animals live longer lives. The worldwide animal stem cell treatment market is being propelled ahead by increased expenditure on animal health in numerous countries throughout the world. One of the primary reasons driving worldwide market expansion is increased investment in Research and development activities in the animal stem cell treatment industry.

The main goal of these efforts is to find out if this technology can be used to treat animals other than dogs, cats, and horses. As a result, the worldwide market for animal stem cell treatment is predicted to grow significantly in the future years.

The key players in the Animal cell therapies market are Vetstem biopharma, Celavet Inc., Kintaro Cells Power, Magellan Stem Cells, U.S. Stem Cell, Cells Power Japan, J-ARM, Animal Care Stem, Cell Therapy Sciences, VetCell Therapeutics. These are the global market players of animal stem cell therapy market.

Recent Innovations in the Animal Stem Cell Therapy Market: a Snapshot

• The five-year exploratory study on Parkinson's disease by Celavie Biosciences advanced in May 2020. The company is creating regenerative stem cell therapies for the treatment of Parkinson's disease and other disorders affecting the central nervous system. There have been encouraging results from exploratory clinical trials Celavie Biosciences conducted with OK99 stem cells to treat Parkinson's disease.
• In September 2020, the US FDA approved intravenous allogeneic MSCs as an IND (investigational new drug) for the treatment of moderate to severe COVID-19.
• In August 2020, Pluristem (Israel) and Abu Dhabi Stem Cells Center (UAE) started collaborating on the development of stem cell therapies for the treatment of COVID-19.

Animal Stem Cell Therapy Market Scope

Key Segments of the Global Animal Stem Cell Therapy Market

 Application Overview, 2022-2029 (USD Million)

• Cat
• Horse
• Dog
• Others

 End Users Overview, 2022-2029 (USD Million)

• Veterinary Hospitals
• Veterinary Clinics
• Research Organizations

Regional Overview, 2022-2029 (USD Million)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

South America

• Mexico
• Brazil
• Rest of South America

Middle East and South Africa